The Janus Pharma Insights cover art

The Janus Pharma Insights

The Janus Pharma Insights

Written by: Rohit Mehmi
Listen for free

The Janus Pharma Insights is a podcast by Janus Biotech focused on India’s evolving pharmaceutical and healthcare industry. From pharmaceutical manufacturing, PCD pharma franchise, and third-party manufacturing to skincare, nutraceuticals, healthcare innovation, and pharma business growth — this podcast explores the ideas, trends, and strategies shaping the future of the pharma sector.

Each episode brings practical discussions, industry insights, manufacturing knowledge, and healthcare business conversations designed for pharma professionals, distributors, healthcare entrepreneurs, and growing pharmaceutical brands.Powered by Janus Biotech, this podcast shares trusted pharmaceutical industry insights backed by years of experience in India’s healthcare and pharma manufacturing ecosystem.

Explore more at Janus Biotech.Janus Biotech
Art Cooking Food & Wine Hygiene & Healthy Living
Episodes
  • What to Check Before Choosing a Nephrology PCD Pharma Company
    Oct 6 2026
    Episode 14. Nephrology is a high-value, specialist-driven franchise segment — but most distributors don't know what to specifically check before signing with any company. This episode covers the four things that actually matter: dedicated nephrology product range, DCGI approval for nephrology indications, cold chain capability for temperature-sensitive molecules, and division-specific monopoly rights. Full checklist at Janus Biotech's guide on what to check before choosing a nephrology PCD pharma company. Also explore Janus Biotech's PCD franchise and third party manufacturing services. Earlier episodes covered how much a general range PCD franchise costs, gynae PCD franchise opportunity, what Biapenem is and how it works, and Vonoprazan PCD opportunity.
    👉 https://janus.co.in/what-to-check-before-choosing-nephrology-pcd-pharma-company/
    Show More Show Less
    20 mins
  • What Is Biapenem and How Does It Work Against Bacterial Infections
    Sep 23 2026
    Episode 13. Biapenem is a carbapenem antibiotic — the class doctors reach for when other antibiotics fail. This episode answers directly: what Biapenem is, how it works by blocking bacterial cell wall synthesis, what infections it treats — septicemia, hospital-acquired pneumonia, complicated UTIs, intra-abdominal infections — and what makes it different from other carbapenems like Meropenem. Full guide at Janus Biotech's Biapenem injection guide. Also explore Janus Biotech's critical care range and contract manufacturing services. Earlier episodes covered how much a general range PCD franchise costs, gynae PCD franchise opportunity, why pharma brands choose Janus for contract manufacturing, Vonoprazan PCD opportunity, and the rise of niacinamide serum manufacturing. 👉 https://janus.co.in/how-does-biapenem-injection-work-against-bacterial-infections/
    Show More Show Less
    22 mins
  • How Much Does It Cost to Start a General Range PCD Pharma Franchise
    Sep 15 2026
    Episode 12. Between ₹60,000 and ₹1,75,000 — that's the realistic investment to start a general range PCD pharma franchise in India in 2026. This episode breaks down exactly where that money goes, what profit margins to expect across antibiotics, antacids, analgesics, and nutraceuticals, what documents you actually need, and how to choose the right franchise partner. Full investment guide at Janus Biotech's general range PCD pharma franchise breakdown. Also explore Janus Biotech's top 10 gynae PCD pharma companies guide and ethical monopoly marketing franchise. Earlier episodes covered gynae PCD franchise, why pharma brands choose Janus Biotech for contract manufacturing, choosing a niacinamide serum manufacturer, the future of Vonoprazan PCD, Janus Biotech as a company, and the rise of niacinamide serum manufacturing. 👉 https://janus.co.in/general-range-pcd-pharma-franchise-investment-requirements-profit-potential/
    Show More Show Less
    21 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet